The Tirzepatide program at Hawaii Wellness Clinic is particularly well suited for patients who have a BMI of 30 or greater, or 27 or greater with weight-related health conditions, have tried semaglutide or other GLP-1 medications without achieving adequate results, have significant insulin resistance, metabolic syndrome, or type 2 diabetes requiring stronger metabolic intervention, need more powerful appetite suppression to manage persistent hunger and cravings, are seeking the most aggressive non-surgical, medically supervised weight loss results currently available, or want to address substantial cardiovascular risk factors such as elevated triglycerides, low HDL, and elevated blood sugar alongside weight loss
Aim for 1.62.2 grams per kilogram of your body weight, distributed across four meals
The Labon formulation features the SPECIAL base
Industry Analysis Published: December 22, 2025 Content Category: Dietary Supplements - Weight Management Regulatory Framework: DSHEA supplement regulations, FTC endorsement guidelines, FDA dietary supplement guidance Target Market: New Year 2026 Weight Loss Season
/assets/images/provider/photos/1922393.jpg)
